NS Healthcare is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
Home » pressreleases » Expansion of probiotics facility strengthens DuPont’s position as leader in probiotics production

Supporting mother and infant well-being

Press
Release

Expansion of probiotics facility strengthens DuPont’s position as leader in probiotics production

DuPont Nutrition & Health (DuPont) has announced a substantial upgrade to its probiotics pilot facility in Madison, Wisconsin.

The $10 million investment strengthens and emboldens DuPont’s current impressive position as a leader in the probiotics industry, allowing for increased pace of new product development and significantly improved delivery times on pilot material for clinical trials and customer evaluations.

Construction on the Madison probiotics pilot area, completed in phases over the last six months, provides increased capacity and speed for new product development. This in turn improves overall scale up capability and a more seamless transition to commercial scale production.

"Given the explosive rise in demand for probiotics products all around the globe, this project allows us to aggressively pursue our goal to be the No. 1 probiotics supplier in the world," said DuPont Nutrition & Health president Matthias Heinzel. "These expansion efforts show our commitment to becoming bigger and stronger with our capability to meet demand, and our facilities, and qualified staff to handle the significant growth we foresee in this sector."

The pilot area features new, state-of-the-art equipment, data collection, laboratories, instrumentation and specialised work space for probiotic development and scale up. The upgrades that quadrupled the pilot area have already increased bandwidth to simultaneously run more development projects while improving scale up efficiency and time to market.

"With all the enhancements, we are better able to meet customer demand for new probiotics at a much faster pace," said Kurt Fenster, bioProcess development group manager, Culture Manufacturing Technology at DuPont Nutrition & Health. "Moving forward, we expect to substantially increase our speed to deliver products to customers."

DuPont Nutrition & Health combines in-depth knowledge of food and nutrition with current research and expert science to deliver unmatched value to the food, beverage and dietary supplement industries. We are innovative solvers, drawing on deep consumer insights and a broad product portfolio to help our customers turn challenges into high-value business opportunities.

More information is available at www.food.dupont.com.

DuPont (NYSE: DD) has been bringing world-class science and engineering to the global marketplace in the form of innovative products, materials and services since 1802. The company believes that by collaborating with customers, governments, NGOs, and thought leaders we can help find solutions to such global challenges as providing enough healthy food for people everywhere, decreasing dependence on fossil fuels, and protecting life and the environment.

For additional information about DuPont and its commitment to inclusive innovation, please visit http://www.dupont.com.

Contact Supporting mother and infant well-being

Supporting mother and infant well-being